Clinical Trial Update: An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing intravenous oxytocin to placebo in autism, using fMRI to assess response inhibition and face processing; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Anagnostou, Evdokia, M.D. | Conditions: Autism | Phase 1 | Status: COMPLETED